PHARMACYTE BIOTECH, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PHARMACYTE BIOTECH, INC. (PMCB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 61.99 million shares for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-07-31 was 61.99M shares, a 203.91% increase year-over-year.
- PHARMACYTE BIOTECH, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-01-31 was 61.99M shares, a 218.08% increase year-over-year.
- PHARMACYTE BIOTECH, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-10-31 was 65.44M shares, a 235.69% increase year-over-year.
- PHARMACYTE BIOTECH, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-07-31 was 20.40M shares, a 4.62% increase year-over-year.
- PHARMACYTE BIOTECH, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 61.99M shares, a 214.01% increase from fiscal 2025.
- PHARMACYTE BIOTECH, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 19.74M shares, a 15.13% decline from fiscal 2024.
- PHARMACYTE BIOTECH, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 23.26M shares, a 128.68% increase from fiscal 2023.
- PHARMACYTE BIOTECH, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 10.17M shares, a 5.93% decline from fiscal 2022.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | 61.99M shares 10-Q · filed 2026-09-14 | |||||||
| 2026-04-30 | 61.99M shares 10-K · filed 2026-07-29 | |||||||
| 2026-01-31 | 61.99M shares 10-Q · filed 2026-03-17 | 61.99M shares 10-Q · filed 2026-03-17 | ||||||
| 2025-10-31 | 65.44M shares 10-Q · filed 2025-12-18 | 65.44M shares 10-Q · filed 2025-12-18 | ||||||
| 2025-07-31 | 20.40M shares 10-Q · filed 2026-09-14 | |||||||
| 2025-04-30 | 19.74M shares 10-K · filed 2026-07-29 | |||||||
| 2025-01-31 | 19.49M shares 10-Q · filed 2026-03-17 | 19.49M shares 10-Q · filed 2026-03-17 | ||||||
| 2024-10-31 | 19.49M shares 10-Q · filed 2025-12-18 | 19.49M shares 10-Q · filed 2025-12-18 | ||||||
| 2024-07-31 | 19.50M shares 10-Q · filed 2025-09-15 | |||||||
| 2024-04-30 | 23.26M shares 10-K · filed 2025-08-11 | |||||||
| 2024-01-31 | 19.35M shares 10-Q · filed 2025-03-17 | 19.35M shares 10-Q · filed 2025-03-17 | 25.28M shares 10-Q · filed 2024-03-18 | |||||
| 2023-10-31 | 18.85M shares 10-Q · filed 2024-12-13 | 18.85M shares 10-Q · filed 2024-12-13 | 26.89M shares 10-Q · filed 2023-12-15 | |||||
| 2023-07-31 | 18.85M shares 10-Q · filed 2024-09-17 | |||||||
| 2023-04-30 | 10.17M shares 10-K · filed 2024-08-13 | |||||||
| 2023-01-31 | 10.17M shares 10-Q · filed 2024-03-18 | |||||||
| 2022-10-31 | 9.93M shares 10-Q · filed 2023-12-15 | |||||||
| 2022-07-31 | 9.93M shares 10-Q · filed 2023-09-18 | |||||||
| 2022-04-30 | 10.81M shares 10-K · filed 2023-07-31 | |||||||
| 2022-01-31 | 10.82M shares 10-Q · filed 2023-03-16 | |||||||
| 2021-10-31 | 9.87M shares 10-Q · filed 2022-12-14 | |||||||
| 2021-07-31 | 45.31K shares 10-Q · filed 2022-09-14 | |||||||
| 2021-04-30 | 44.31K shares 10-K · filed 2022-07-28 | |||||||
| 2021-01-31 | 85.24K shares 10-Q · filed 2022-03-15 | 127.86M shares 10-Q · filed 2021-03-12 | ||||||
| 2020-10-31 | 100.97K shares 10-Q · filed 2021-12-14 | 151.46M shares 10-Q · filed 2020-12-11 | ||||||
| 2020-07-31 | 85.35K shares 10-Q · filed 2021-09-14 | 128.02M shares 10-Q · filed 2020-09-11 | ||||||
| 2020-04-30 | 76.73K shares 10-K · filed 2021-08-10 | 115.09M shares 10-K · filed 2020-08-13 | ||||||
| 2020-01-31 | 142.71M shares 10-Q · filed 2021-03-12 | |||||||
| 2019-10-31 | 133.71M shares 10-Q · filed 2019-12-23 | 133.71M shares 10-Q · filed 2020-12-11 | ||||||
| 2019-07-31 | 154.36M shares 10-Q · filed 2020-09-11 | |||||||
| 2019-04-30 | 149.53M shares 10-K · filed 2020-08-13 | |||||||
| 2019-01-31 | 136.03M shares 10-Q · filed 2019-03-14 | 136.03M shares 10-Q · filed 2019-03-14 | ||||||
| 2018-10-31 | 133.76M shares 10-Q · filed 2019-12-23 | 133.76M shares 10-Q · filed 2019-12-23 | ||||||
| 2018-07-31 | 132.56M shares 10-Q · filed 2019-09-13 | |||||||
| 2018-04-30 | 129.24M shares 10-K · filed 2019-08-13 | |||||||
| 2018-01-31 | 144.10M shares 10-Q · filed 2019-03-14 | 144.10M shares 10-Q · filed 2019-03-14 | ||||||
| 2017-10-31 | 139.32M shares 10-Q · filed 2018-12-14 | 139.32M shares 10-Q · filed 2018-12-14 | ||||||
| 2017-07-31 | 156.44M shares 10-Q · filed 2018-09-12 | |||||||
| 2017-04-30 | 146.95M shares 10-K · filed 2018-07-20 | |||||||
| 2017-01-31 | 148.13M shares 10-Q · filed 2018-03-19 | 148.13M shares 10-Q · filed 2018-03-19 | ||||||
| 2016-10-31 | 166.12M shares 10-Q · filed 2017-12-14 | 166.12M shares 10-Q · filed 2017-12-14 | ||||||
| 2016-07-31 | 166.12M shares 10-Q · filed 2017-09-13 | |||||||
| 2016-04-30 | 153.02M shares 10-K · filed 2017-07-27 | |||||||
| 2016-01-31 | 153.02M shares 10-Q · filed 2017-03-13 | 153.02M shares 10-Q · filed 2016-03-08 | 153.02M shares 10-Q · filed 2017-03-13 | 153.02M shares 10-Q · filed 2016-03-08 | ||||
| 2015-10-31 | 125.42M shares 10-Q · filed 2016-12-02 | 125.42M shares 10-Q · filed 2016-12-02 | ||||||
| 2015-07-31 | 125.42M shares 10-Q · filed 2016-09-06 | |||||||
| 2015-04-30 | 125.42M shares 10-K · filed 2016-07-29 | |||||||
| 2015-01-31 | 82.97M shares 10-Q · filed 2016-03-08 | 82.97M shares 10-Q · filed 2016-03-08 | ||||||
| 2014-04-30 | 57.67M shares 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |